lipid-a and Pneumonia--Pneumococcal

lipid-a has been researched along with Pneumonia--Pneumococcal* in 1 studies

Other Studies

1 other study(ies) available for lipid-a and Pneumonia--Pneumococcal

ArticleYear
The Biosynthetic Monophosphoryl Lipid A Enhances the Therapeutic Outcome of Antibiotic Therapy in Pneumococcal Pneumonia.
    ACS infectious diseases, 2021, 08-13, Volume: 7, Issue:8

    Alternative treatment strategies against bacterial infections are required to decrease the use of antibiotics. This study tested the hypothesis that stimulation of the innate immune receptor Toll-like receptor 4 can be combined with antibiotics to improve the treatment of invasive pneumonia. The efficacy of the biosynthetic monophosphoryl lipid A (MPLA), a clinically approved Toll-like receptor 4 activator, was tested in a mouse model of

    Topics: Animals; Anti-Bacterial Agents; Lipid A; Mice; Pneumonia, Pneumococcal; Treatment Outcome

2021